Last ¥2,152 JPY
Change Today +66.00 / 3.16%
Volume 509.1K
4559 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 04/21/14 All times are local (Market data is delayed by at least 15 minutes).

zeria pharmaceutical co ltd (4559) Snapshot

Open
¥2,120
Previous Close
¥2,086
Day High
¥2,170
Day Low
¥2,120
52 Week High
01/21/14 - ¥3,170
52 Week Low
06/14/13 - ¥1,185
Market Cap
114.3B
Average Volume 10 Days
165.0K
EPS TTM
¥122.93
Shares Outstanding
53.1M
EX-Date
03/27/14
P/E TM
17.5x
Dividend
¥27.73
Dividend Yield
1.29%
Current Stock Chart for ZERIA PHARMACEUTICAL CO LTD (4559)

Related News

No related news articles were found.

zeria pharmaceutical co ltd (4559) Related Businessweek News

No Related Businessweek News Found

zeria pharmaceutical co ltd (4559) Details

Zeria Pharmaceutical Co., Ltd. manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents. It also provides cosmetics, health foods, alcoholic beverages, carbonated beverages, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, measuring equipment, and analytical equipment. The company’s ethical pharmaceutical products include functional dyspepsia treatment products, histamine h2 receptor antagonists, zinc containing anti-ulcerants, oral bowel cleansing products, laxative products, ulcerative colitis remedies, and proton pump inhibitors in the gastrointestinal field, as well as hypophosphatemia treatment products, long-acting calcium channel blockers, absorbable topical hemostats, sclerotherapy products for leg varicose veins, enzymatic hemostatics, anti-platelet oral jellies, oral non-steroidal anti-inflammatory products, anti-leukopenia after radiotherapy products, topical non-steroidal anti-inflammatory products, anti-inflammatory topical blood circulation enhancers, and non-steroidal anti-inflammatory ophthalmic solutions. Its products also include OTC drugs and products, such as self-prevention products, remedies for gastrointestinal diseases, dermal remedies/cosmeceuticals, ophthalmic solutions, cold remedies, nutrient tonics, and topical anti-inflammatory analgesics. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

1,298 Employees
Last Reported Date: 06/27/13
Founded in 1955

zeria pharmaceutical co ltd (4559) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zeria pharmaceutical co ltd (4559) Key Developments

Zeria Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Feb 05, 2014

Zeria Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Feb 05, 2014

Zeria Pharmaceutical Co., Ltd. to Report Q2, 2014 Results on Nov 08, 2013

Zeria Pharmaceutical Co., Ltd. announced that they will report Q2, 2014 results on Nov 08, 2013

Vifor Pharma Signs Licensing Agreement with Zeria Pharmaceutical

On August 13, 2013, Vifor Pharma, Ltd. has entered into an exclusive licensing agreement with Zeria Pharmaceutical Co., Ltd. for the development and commercialization of Ferinject(R) (ferric carboxymaltose) for the treatment of iron deficiency anaemia in Japan. Under the terms of the agreement, Zeria will be responsible for all development and commercialization activities for Ferinject(R) in Japan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4559:JP ¥2,152.00 JPY +66.00

4559 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4559.
View Industry Companies
 

Industry Analysis

4559

Industry Average

Valuation 4559 Industry Range
Price/Earnings 18.5x
Price/Sales 1.6x
Price/Book 2.3x
Price/Cash Flow 21.6x
TEV/Sales 1.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZERIA PHARMACEUTICAL CO LTD, please visit www.zeria.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.